*** Welcome to piglix ***

CYP2C9

CYP2C9
CYP2C9 1OG2.png
Available structures
PDB Human UniProt search: PDBe RCSB
Identifiers
Aliases CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9, cytochrome P450 family 2 subfamily C member 9, Cytochrome P450 2C9
External IDs OMIM: 601130 MGI: 1917138 HomoloGene: 133566 GeneCards: CYP2C9
EC number 1.14.13.48
RNA expression pattern
PBB GE CYP2C9 214421 x at fs.png

PBB GE CYP2C9 216025 x at fs.png

PBB GE CYP2C9 216661 x at fs.png
More reference expression data
Orthologs
Species Human Mouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)

NM_000771

NM_001011707

RefSeq (protein)

NP_000762

n/a

Location (UCSC) Chr 10: 94.94 – 94.99 Mb Chr 19: 39.11 – 39.19 Mb
PubMed search

1OG2, 1OG5, 1R9O, 4NZ2

NM_000771

NM_001011707

NP_000762

n/a

Cytochrome P450 2C9 (abbreviated CYP2C9) is an enzyme that in humans is encoded by the CYP2C9 gene.

CYP2C9 is an important enzyme with a major role in the oxidation of both xenobiotic and endogenous compounds. CYP2C9 makes up about 18% of the protein in liver microsomes (data only for antifungal). Some 100 therapeutic drugs are metabolized by CYP2C9, including drugs with a narrow therapeutic index such as warfarin and phenytoin and other routinely prescribed drugs such as acenocoumarol, tolbutamide, losartan, glipizide, and some nonsteroidal anti-inflammatory drugs. By contrast, the known extrahepatic CYP2C9 often metabolizes important endogenous compound such as 5-hydroxytryptamine and, owing to its epoxygenase activity, various polyunsaturated fatty acids, converting these fatty acids to a wide range of biological active products.


...
Wikipedia

...